Caldan Therapeutics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Out of Business

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Liquidation

Caldan Therapeutics General Information

Description

Developer of novel therapeutics technology designed to treat diabetes and other inflammatory diseases. The company's technology addresses multiple aspects of T2D pathophysiology including insulin secretion, insulin sensitivity, islet cell protection, and anti-developer of novel therapeutics technology designed to treat diabetes, and other inflammatory diseases, inflammatory activity in muscle, liver, and adipose tissue, enabling patients to have glucose-lowering agents in their bodies.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 7-11 Melville Street
  • Edinburgh EH3 7PE
  • Scotland, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 7-11 Melville Street
  • Edinburgh EH3 7PE
  • Scotland, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Caldan Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Bankruptcy: Liquidation 17-Sep-2024 Completed Bankruptcy: Liquidation
5. Later Stage VC 11-Feb-2021 Completed Generating Revenue
4. Early Stage VC (Series A2) 07-Oct-2019 Completed Generating Revenue
3. Early Stage VC (Series A) 23-Jun-2017 Completed Generating Revenue
2. Early Stage VC (Series A1) 03-Nov-2015 Completed Startup
1. University Spin-Out 14-Sep-2015 Completed Startup
To view Caldan Therapeutics’s complete valuation and funding history, request access »

Caldan Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Series A
Series A 4,264,393 $0.001239 $1.16 $1.16 1x $1.16 54.27%
To view Caldan Therapeutics’s complete cap table history, request access »

Caldan Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel therapeutics technology designed to treat diabetes and other inflammatory diseases. The company's tec
Drug Discovery
Edinburgh, United Kingdom
4 As of 2024

Newton, MA
 

Plymouth Meeting, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Caldan Therapeutics Competitors (69)

One of Caldan Therapeutics’s 69 competitors is Adiso Therapeutics, a Venture Capital-Backed company based in Newton, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Adiso Therapeutics Venture Capital-Backed Newton, MA
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Xalud Therapeutics Venture Capital-Backed New York, NY
Annexon Biosciences Formerly VC-backed Brisbane, CA
PIPr Therapeutics Venture Capital-Backed Durham, NC
You’re viewing 5 of 69 competitors. Get the full list »

Caldan Therapeutics Patents

Caldan Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2020515636-A Pharmaceutical compound Active 24-Mar-2017
JP-7099672-B2 Pharmaceutical compound Active 24-Mar-2017
GB-201704714-D0 Pharmaceutical compounds Inactive 24-Mar-2017
CA-3057415-A1 Tetrahydro-benzo[d]azepine derivatives as gpr120 modulators Pending 24-Mar-2017
EP-3601229-A1 Tetrahydro-benzo[d]azepine derivatives as gpr120 modulators Active 24-Mar-2017 C07D217/04
To view Caldan Therapeutics’s complete patent history, request access »

Caldan Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Caldan Therapeutics FAQs

  • When was Caldan Therapeutics founded?

    Caldan Therapeutics was founded in 2015.

  • Where is Caldan Therapeutics headquartered?

    Caldan Therapeutics is headquartered in Edinburgh, United Kingdom.

  • What is the size of Caldan Therapeutics?

    Caldan Therapeutics has 4 total employees.

  • What industry is Caldan Therapeutics in?

    Caldan Therapeutics’s primary industry is Drug Discovery.

  • Is Caldan Therapeutics a private or public company?

    Caldan Therapeutics is a Private company.

  • What is Caldan Therapeutics’s current revenue?

    The current revenue for Caldan Therapeutics is .

  • How much funding has Caldan Therapeutics raised over time?

    Caldan Therapeutics has raised $18.2M.

  • Who are Caldan Therapeutics’s competitors?

    Adiso Therapeutics, Inovio Pharmaceuticals, Xalud Therapeutics, Annexon Biosciences, and PIPr Therapeutics are some of the 69 competitors of Caldan Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process